Literature DB >> 8690566

The role of perspective in defining economic measures for the evaluation of medical technology.

A J Davidoff1, N R Powe.   

Abstract

Perspectives in an economic analysis of medical technology reflect who makes decisions about the use of or payment for medical resources. Commonly used perspectives include those of providers, insurers, the individual, and society. Perspective is a critical determinant of study design, affecting the time horizon, types of resources considered, and economic cost measures assigned to those resources. Individuals involved in technology assessment for either research or policy-making purposes should be aware of the complexities of defining costs from different perspectives.

Mesh:

Year:  1996        PMID: 8690566     DOI: 10.1017/s026646230000934x

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  7 in total

Review 1.  Methodological hurdles in conducting pharmacoeconomic analyses.

Authors:  J D Rizzo; N R Powe
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 2.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 3.  Evidence from cost-effectiveness research.

Authors:  Katia Noyes; Robert G Holloway
Journal:  NeuroRx       Date:  2004-07

Review 4.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Unit costs of inpatient hospital days.

Authors:  Jan B Oostenbrink; Tineke Buijs-Van der Woude; Michel van Agthoven; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors.

Authors:  Katia Noyes; Eric A Singer; Edward M Messing
Journal:  Curr Opin Urol       Date:  2008-09       Impact factor: 2.309

7.  Protocol for the economic evaluation of a community-based intervention to improve growth among children under two in rural India (CARING trial).

Authors:  Jolene Skordis-Worrall; Rajesh Sinha; Amit Kumar Ojha; Soumendra Sarangi; Nirmala Nair; Prasanta Tripathy; H S Sachdev; Sanghita Bhattacharyya; Rajkumar Gope; Shibanand Rath; Suchitra Rath; Aradhana Srivastava; Neha Batura; Anni-Maria Pulkki-Brännström; Anthony Costello; Andrew Copas; Naomi Saville; Audrey Prost; Hassan Haghparast-Bidgoli
Journal:  BMJ Open       Date:  2016-11-02       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.